Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 27.97%500.41M | 61.84%765.28M | -42.08%377.95M | -57.78%334.84M | -50.45%391.04M | -35.16%472.86M | -15.41%652.5M | -2.72%793.04M | 20.18%789.18M | 20.22%729.32M |
| Transactional financial assets | ---- | ---- | ---- | ---- | ---- | ---- | 10,252.58%18.43M | --18.43M | ---- | --0 |
| Notes receivable and accounts receivable | 18.39%2.56B | -3.49%2.31B | 19.65%2.04B | 34.09%1.91B | 49.60%2.16B | 96.52%2.4B | 70.16%1.71B | 29.30%1.42B | 32.19%1.44B | 0.26%1.22B |
| -Notes receivable | 14,551.15%6.49M | 139.83%5.18M | 1,640.80%41.03M | 26.91%20.89M | -99.99%44.31K | -98.82%2.16M | -98.12%2.36M | -79.70%16.46M | 331.92%302.33M | 120.09%182.34M |
| -Accounts receivable | 18.09%2.55B | -3.62%2.31B | 17.41%2B | 34.18%1.89B | 89.19%2.16B | 130.85%2.39B | 94.19%1.7B | 37.96%1.41B | 11.68%1.14B | -8.50%1.04B |
| Other receivables (including interest and dividends) | -8.61%79.58M | -19.41%75.98M | 521.69%107.44M | 572.77%100.66M | 343.34%87.08M | 514.74%94.28M | -49.71%17.28M | -70.00%14.96M | -83.94%19.64M | -17.24%15.34M |
| -Dividend receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Accrued interest receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Other receivable | ---- | -19.41%75.98M | ---- | ---- | ---- | 514.74%94.28M | ---- | -70.00%14.96M | ---- | -17.24%15.34M |
| Contractual assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Advance payment | -47.18%58.65M | 47.20%102.79M | 48.71%109.75M | 77.99%66.09M | 333.90%111.04M | 257.74%69.83M | 330.67%73.8M | 98.07%37.13M | 303.14%25.59M | 34.65%19.52M |
| Inventories | 77.62%855.29M | 257.50%1.11B | 52.22%693.42M | -15.40%721.2M | 35.30%481.52M | -2.30%309.81M | 35.12%455.55M | 179.92%852.49M | 21.11%355.9M | -3.24%317.1M |
| Receivable financing | 112.44%105.4M | 147.08%80.56M | -7.86%83.8M | 53.45%110.63M | -56.29%49.61M | -39.36%32.6M | -39.55%90.94M | -39.97%72.09M | 17.47%113.51M | -22.43%53.76M |
| Assets held for sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Non-current assets due within one year | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Other current assets | 322.90%103.76M | 118.62%125.04M | 123.93%70.91M | -29.99%71.43M | -9.14%24.54M | 182.52%57.2M | 80.11%31.67M | 1,151.76%102.03M | 384.19%27M | 170.49%20.25M |
| Total current assets | 28.91%4.26B | 33.11%4.57B | 14.39%3.49B | 0.01%3.32B | 19.11%3.31B | 44.57%3.43B | 30.70%3.05B | 37.07%3.31B | 21.90%2.78B | 5.03%2.37B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Other debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Other equity investment | 0.00%2.24M | 0.00%2.24M | 12.00%2.24M | 12.00%2.24M | 49.33%2.24M | 49.33%2.24M | 33.33%2M | 33.33%2M | 0.00%1.5M | 0.00%1.5M |
| Other non-current financial assets | 0.00%24M | 0.00%24M | 0.00%24M | 0.00%24M | 0.00%24M | 0.00%24M | 0.00%24M | 0.00%24M | 0.00%24M | 0.00%24M |
| Investment real estate | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -57.69%20.17M | -54.99%21.77M |
| Long-term equity investment | 14.31%1.9M | 20.40%2M | -4.31%2.28M | 1.38%2.57M | -23.78%1.66M | -15.40%1.66M | -18.05%2.38M | -12.69%2.54M | -10.79%2.18M | -19.62%1.96M |
| Long term receivable account | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Fixed assets | ---- | 38.08%2.42B | ---- | ---- | ---- | 1.33%1.75B | ---- | -9.24%1.66B | ---- | -4.45%1.73B |
| Fixed assets liquidation | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.95M | ---- | ---- |
| Constru in process | ---- | 477.97%145.31M | ---- | ---- | ---- | -67.64%25.14M | ---- | 16.89%58.14M | ---- | -50.21%77.7M |
| Productive biological assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Oil and gas assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Intangible assets | 61.63%129.3M | 81.72%135.68M | 83.37%141.76M | 86.23%148.48M | 3.14%79.99M | -4.24%74.66M | 1.33%77.31M | 1.90%79.73M | -0.83%77.56M | 21.14%77.97M |
| Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Goodwill | -16.13%402.43M | -16.13%402.43M | 38.63%402.43M | 38.63%402.43M | 53.18%479.83M | 53.18%479.83M | -7.33%290.29M | -7.33%290.29M | -14.40%313.24M | -14.40%313.24M |
| Long deferred expense | -39.03%71.1M | -40.48%73.34M | -32.77%84.3M | -39.94%82.21M | -9.69%116.61M | -6.20%123.22M | 0.18%125.38M | 6.38%136.87M | -2.14%129.12M | -4.06%131.37M |
| Deferred tax assets | 84.14%74.04M | 70.04%67.28M | 32.65%56.94M | -0.96%59.13M | -57.71%40.21M | -54.29%39.57M | -50.49%42.92M | -21.25%59.7M | -12.74%95.09M | -16.76%86.56M |
| Usufruct assets | 79.49%33.85M | 117.09%35.77M | 13.81%22.81M | 12.52%25.38M | -22.55%18.86M | -38.38%16.48M | -32.76%20.05M | -9.48%22.56M | 143.30%24.35M | 133.59%26.74M |
| Other non current assets | -78.64%9.72M | -92.67%3.42M | -95.73%1.45M | -94.83%1.73M | 38.32%45.52M | 106.56%46.62M | 63.56%33.92M | 158.06%33.55M | 142.71%32.91M | -0.39%22.57M |
| Total non current assets | 14.03%3.34B | 28.05%3.31B | 42.96%3.28B | 38.98%3.29B | 17.44%2.93B | 2.82%2.59B | -9.91%2.29B | -7.55%2.37B | -6.49%2.49B | -8.47%2.52B |
| Total assets | 21.92%7.6B | 30.94%7.88B | 26.65%6.76B | 16.25%6.61B | 18.32%6.23B | 23.10%6.02B | 9.51%5.34B | 14.12%5.68B | 6.59%5.27B | -2.38%4.89B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 67.92%1.26B | 44.09%1.25B | -13.37%731.11M | -3.75%767.32M | 64.30%752.2M | 83.57%865.94M | 75.63%843.93M | 68.42%797.2M | -1.48%457.81M | -4.20%471.74M |
| Transactional financial liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Notes payable and accounts payable | -1.48%2.23B | 11.61%2.65B | 6.41%2.08B | 1.30%2.18B | 19.16%2.26B | 59.27%2.37B | 50.02%1.95B | 63.21%2.15B | 39.01%1.9B | 0.03%1.49B |
| -Notes payable | -32.84%148.11M | -62.92%131.16M | -15.66%272.43M | -48.83%171.26M | -68.86%220.54M | -27.27%353.73M | -29.40%323M | -26.42%334.68M | 46.74%708.3M | -6.91%486.37M |
| -Accounts payable | 1.92%2.08B | 24.66%2.52B | 10.78%1.8B | 10.53%2.01B | 71.66%2.04B | 101.22%2.02B | 93.11%1.63B | 110.42%1.82B | 34.78%1.19B | 3.78%1B |
| Contract liabilities | -64.81%19.36M | -56.00%20.27M | 920.69%31.31M | 2,067.04%28.14M | 4,262.67%55M | 2,338.19%46.07M | 89.09%3.07M | -10.24%1.3M | -78.65%1.26M | -68.74%1.89M |
| Advance receipts | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --200M | ---- | --0 |
| Salaries payable | 18.62%71.4M | 23.05%77.81M | -3.20%62.54M | -0.81%75.23M | -3.07%60.2M | 7.14%63.23M | 17.94%64.6M | 7.06%75.84M | 2.41%62.1M | -1.02%59.02M |
| Taxs payable | 179.66%107.15M | 141.13%109.87M | 295.48%105.25M | 139.50%108.69M | 318.43%38.31M | 143.01%45.56M | 7.77%26.61M | 41.96%45.38M | -77.85%9.16M | -34.27%18.75M |
| Other payable (including interest and dividends) | -3.70%213.45M | -5.08%256M | 566.17%280.3M | 710.47%331.76M | 775.28%221.66M | 975.32%269.71M | 85.16%42.08M | 68.16%40.93M | 70.44%25.32M | -73.29%25.08M |
| -Interest payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Dividend payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Other payable | ---- | -5.08%256M | ---- | ---- | ---- | 975.32%269.71M | ---- | 68.16%40.93M | ---- | -73.29%25.08M |
| Hold and for sell liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Non current liabilities due within one year | 63.63%660.74M | 82.90%575.63M | 96.43%625.13M | 23.33%430.96M | 138.40%403.8M | 68.50%314.73M | 68.92%318.24M | 80.44%349.42M | 17.14%169.38M | 19.32%186.78M |
| Other current liabilities | -94.44%2.85M | -88.67%6.72M | -85.35%5.85M | -58.39%20.4M | -71.80%51.18M | -42.72%59.33M | -58.14%39.92M | -9.08%49.02M | 198.99%181.45M | 125.97%103.59M |
| Total current liabilities | 18.80%4.56B | 22.41%4.94B | 19.09%3.92B | 6.23%3.94B | 37.08%3.84B | 71.32%4.04B | 51.68%3.29B | 71.12%3.71B | 29.95%2.8B | -0.66%2.36B |
| Current liabilities | ||||||||||
| Long term loan | -22.21%401.19M | 163.67%432.65M | 79.22%398.81M | -8.00%197.23M | 19.25%515.77M | -62.37%164.09M | -56.57%222.52M | -59.81%214.38M | 4.07%432.5M | 5.80%436.1M |
| Bonds payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Perpetual Debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Long term account payable | ---- | 3,139.56%776.58M | ---- | ---- | ---- | -41.22%23.97M | ---- | -41.32%10.19M | ---- | -8.02%40.78M |
| Long term salaries pay | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Estimate liabilities | --8M | --6.17M | --4.5M | --4.5M | ---- | ---- | ---- | ---- | ---- | --0 |
| Deferred tax liabilities | 812.77%63.55M | 613.55%49.28M | 521.20%44.24M | 637.88%45.82M | -11.43%6.96M | -15.42%6.91M | -14.13%7.12M | -28.08%6.21M | 80.45%7.86M | 87.42%8.16M |
| Long term deferred income | -0.72%154.81M | -7.45%149.26M | -11.15%156.27M | -10.55%162.81M | -16.45%155.93M | -7.16%161.27M | -1.62%175.89M | -0.14%182.02M | 0.11%186.63M | -4.69%173.7M |
| Lease liabilities | 55.07%17.79M | 205.47%21.49M | 33.67%18.28M | 10.33%15.78M | -37.94%11.47M | -61.83%7.04M | -34.95%13.68M | -7.16%14.3M | 238.47%18.48M | 158.52%18.44M |
| Other non current liabilities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Total non current liabilities | 103.66%1.48B | 295.14%1.44B | 233.68%1.41B | 194.33%1.26B | 6.97%726.45M | -46.35%363.27M | -42.30%423.63M | -43.59%427.1M | 6.37%679.09M | 4.14%677.18M |
| Total liabilities | 32.30%6.04B | 44.92%6.38B | 43.57%5.33B | 25.65%5.2B | 31.21%4.57B | 45.06%4.4B | 27.91%3.71B | 41.44%4.14B | 24.56%3.48B | 0.37%3.03B |
| Shareholders equity | ||||||||||
| Paid-in capital | -1.20%482.56M | -1.20%482.56M | -0.01%488.36M | 0.00%488.41M | 0.00%488.41M | 0.00%488.41M | 0.00%488.41M | 0.00%488.41M | 0.00%488.41M | 3.95%488.41M |
| Other equity instruments | ---- | ---- | ---131.53M | ---131.53M | ---- | ---- | ---- | ---- | ---- | --0 |
| -Equity of prefer stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| -Equity of Perpetual debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Capital reserve funds | -16.07%1.22B | -16.44%1.22B | -8.06%1.34B | -8.48%1.33B | -1.08%1.46B | -1.08%1.46B | -1.08%1.46B | -1.08%1.46B | 0.32%1.47B | 12.15%1.47B |
| Surplus reserve funds | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M | 0.00%42.53M |
| Retained profit | 17.34%-441.61M | 11.42%-478.13M | 6.33%-525.32M | 9.65%-532.12M | -35.22%-534.24M | -61.63%-539.79M | -147.58%-560.84M | -283.89%-588.94M | -853.53%-395.08M | -355.23%-333.96M |
| Less:Treasury stock | -62.32%47.11M | -62.32%47.11M | -62.32%47.11M | -61.57%48.03M | 0.00%125M | 0.00%125M | 0.00%125M | 0.00%125M | 0.00%125M | 0.00%125M |
| Other composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Ordinary risk reserve funds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Specific reserves | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
| Shareholders equity without minority interests | -5.21%1.26B | -7.99%1.22B | -10.41%1.17B | -9.53%1.15B | -10.46%1.33B | -14.37%1.32B | -21.21%1.3B | -26.18%1.27B | -23.00%1.48B | -15.67%1.54B |
| Minority interests | -11.99%295.49M | -2.97%288.39M | -18.41%264.47M | -6.08%255.91M | 11.09%335.73M | -5.04%297.22M | 1.11%324.14M | -17.52%272.47M | 37.18%302.22M | 100.08%312.99M |
| Total shareholder equity | -6.58%1.55B | -7.07%1.5B | -12.01%1.43B | -8.92%1.41B | -6.81%1.66B | -12.79%1.62B | -17.58%1.62B | -24.79%1.55B | -16.82%1.78B | -6.56%1.86B |
| Total liabilityies and equity | 21.92%7.6B | 30.94%7.88B | 26.65%6.76B | 16.25%6.61B | 18.32%6.23B | 23.10%6.02B | 9.51%5.34B | 14.12%5.68B | 6.59%5.27B | -2.38%4.89B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.